CD40L and IL-4 increased HLA-E expression on the surface of primary CLL cells and non-Hodgkin’s lymphoma (NHL) cell lines, and this decreased NK cell-mediated ADCC via ligation of the inhibitory receptor NKG2A. Here, KLRC1 is linked to B-cell chronic lymphocytic leukemia.